ClassID:

115251

C12Y204/01068 - CPC Classification

Classification description:

Glycosyltransferases (2.4); Hexosyltransferases (2.4.1) Glycoprotein 6-alpha-L-fucosyltransferase (2.4.1.68), i.e. FUT8

Recent Application in this class:
#1
20220389080
2022-12-08

Recombinant chimeric protein for selectins targeting

#2
20220002387
2022-01-06

Compositions and Production of Recombinant AAV Viral Vectors Capable of Glycoengineering In Vivo

#3
20210317499
2021-10-14

AFUCOSYLATED ANTIBODIES AND MANUFACTURE THEREOF

#4
20210188994
2021-06-24

AFUCOSYLATED ANTIBODIES AND MANUFACTURE THEREOF

#5
20210115413
2021-04-22

METHODS OF GLYCOENGINEERING PROTEOGLYCANS WITH DISTINCT GLYCAN STRUCTURES

#6
20210108190
2021-04-15

METHODS AND COMPOSITIONS FOR PRODUCING DOUBLE ALLELE KNOCK OUTS

#7
20200339666
2020-10-29

DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof

#8
20190360015
2019-11-28

ANTIBODY COMPOSITION-PRODUCING CELL

#9
20190112358
2019-04-18

DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof

#10
20190048062
2019-02-14

Recombinant chimeric protein for selectins targeting

#11
20180334665
2018-11-22

Methods and compositions for producing double allele knock outs

#12
20180171028
2018-06-21

Afucosylated protein, cell expressing said protein and associated methods

#13
20170137837
2017-05-18

Plant synthesizing hypoallergenic paucimannose type N-glycan and uses thereof

#14
20160348145
2016-12-01

Antibody composition-producing cell

#15
20150024500
2015-01-22

Methods and compositions for producing double allele knock outs

#16
20140005368
2014-01-02

Low fucose cell lines and uses thereof

#17
20110250643
2011-10-13

Antibody composition-producing cell

#18
20110151513
2011-06-23

SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA-1,6-FUCOSYLTRANSFERASE

#19
20110059115
2011-03-10

Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody

#20
20110052610
2011-03-03

Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation

#21
20110027271
2011-02-03

ANTIBODY COMPOSITION EXHIBITING CELLULAR CYTOTOXICTY DUE TO GLYCOSYLATION

#22
20100143388
2010-06-10

Antibody Composition-Producing Cell

#23
20100028949
2010-02-04

SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA 1,6-FUCOSYLTRANSFERASE

#24
20100015627
2010-01-21

SELECTION METHOD

#25
20100003742
2010-01-07

METHOD FOR REDUCING FUCOSE CONTENTS OF RECOMBINANT PROTEINS

#26
20090228994
2009-09-10

Cells with altered fucosylation and producing antibodies therefrom

#27
20090221065
2009-09-03

Composition for suppressing the expression of fucosyltransferase

#28
20090191592
2009-07-30

Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation

#29
20090191199
2009-07-30

Glycoengineered, recombinant antibody

#30
20080261301
2008-10-23

Antibody composition-producing cell in which enzyme expression is inhibited by RNAi

#31
20080227196
2008-09-18

Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase

#32
20070134759
2007-06-14

Process for producing antibody composition by using rna inhibiting the function of alpha1,6-fucosyltransferase

#33
20070010009
2007-01-11

Antibody Composition-Producing Cell

#34
20060078991
2006-04-13

Antibody composition-producing cell

#35
20060078990
2006-04-13

Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase

#36
20060064781
2006-03-23

Antibody composition-producing cell

#37
20060063254
2006-03-23

Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation

#38
20050262593
2005-11-24

Antibody composition-producing cell

#39
20050216958
2005-09-29

Cells of which genome is modified